CHAPEL HILL, NC, UNITED STATES - Feb 24, 2015 -
WHAT: Rho, a full-service contract research
organization (CRO), will highlight its continued success in drug
development strategies and services to the California life science
industry during the CALBIO 2015 conference, being held March 2-3 in
San Francisco.
Event attendees are invited to stop by Rhos booth (#103) to
learn more about the services they provide to ensure an efficient
and a successful drug development process. Rho focuses on helping
pharmaceutical and biotechnology companies bring their products to
market through high-quality clinical research services. These
services include clinical operations, project management, data
management, data standards, and biostatistics with extensive
experience in many therapeutic areas.
WHO: Rho experts at CALBIO:
- David Cass, Senior Director, Business Development
- Emily Allan, Business Development Associate
WHEN: March 2-3, 2015
WHERE:
San Francisco
Marriott Marquis, Booth #103
780 Mission Street
San Francisco,
California
DETAILS: For media inquiries please
contact Bernadette Miller at Largemouth Communications, (703)
297-5992, bernadette@largemouthpr.com.
ABOUT: Rho, a privately-held, contract
research organization (CRO) located in Chapel Hill, NC, provides a
full range of clinical research services across the entire drug
development process. For 31 years, Rho has been a trusted partner
to some of the industrys leading pharmaceutical, biotechnology,
and medical device companies as well as academic and government
organizations. Our commitment to excellence, our innovative
technologies, and our therapeutic expertise accelerate time to
market, maximize returns on investment, and lead to an exceptional
customer experience. For more information, please visit www.rhoworld.com and follow us
on Twitter.